Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q2 2024 Earnings Call Transcript August 13, 2024
Mersana Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.19986 EPS, expectations were $-0.18.
Operator: Good morning, and welcome to Mersana Therapeutics Second Quarter 2024 Conference Call and Webcast. [Operator instructions]. Please note, this call is being recorded. I would now like to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate...
